6 Einträge gefunden

1. FABP1 expression in human tumors: a tissue microarray study on 17,071 tumors

   1. Dum, David
   2. Ocokoljic, Ana
   3. Lennartz, Maximilian
   4. Hube-Magg, Claudia
   5. Reiswich, Viktor
   6. Höflmayer, Doris
   7. Jacobsen, Frank

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
2. Upregulation of PTTG1 is associated with poor prognosis in prostate cancer

   1. Fraune, Christoph
   2. Yehorov, Serhiy
   3. Luebke, Andreas M
   4. Steurer, Stefan
   5. Hube-Magg, Claudia
   6. Büscheck, Franziska
   7. Höflmayer, Doris

   2020 - Forschungsinformationssystem des UKE
3. Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of PTEN deleted prostate cancers

   1. Luebke, Andreas M
   2. Attarchi-Tehrani, Ali
   3. Meiners, Jan
   4. Hube-Magg, Claudia
   5. Lang, Dagmar S
   6. Kluth, Martina
   7. Tsourlakis, Maria Christina

   2019 - Forschungsinformationssystem des UKE - frei zugänglich
4. Nuclear up regulation of the BRCA1-associated ubiquitinase BAP1 is associated with tumor aggressiveness in prostate cancers lacking the TMPRSS2:ERG fusion

   1. Steurer, Stefan
   2. Schwemmer, Lara
   3. Hube-Magg, Claudia
   4. Büscheck, Franziska
   5. Höflmayer, Doris
   6. Tsourlakis, Maria Christina
   7. Clauditz, Till S

   2019 - Forschungsinformationssystem des UKE
5. Down-Regulation of S100A8 is an Independent Predictor of PSA Recurrence in Prostate Cancer Treated by Radical Prostatectomy

   1. Minner, Sarah
   2. Hager, Dominik
   3. Steurer, Stefan
   4. Höflmayer, Doris
   5. Tsourlakis, Maria Christina
   6. Möller-Koop, Christina
   7. Clauditz, Till S

   2019 - Forschungsinformationssystem des UKE - frei zugänglich
6. Up-regulation of Biglycan is Associated with Poor Prognosis and PTEN Deletion in Patients with Prostate Cancer

   1. Jacobsen, Frank
   2. Kraft, Juliane
   3. Schroeder, Cornelia
   4. Hube-Magg, Claudia
   5. Kluth, Martina
   6. Lang, Dagmar S
   7. Simon, Ronald

   2017 - Forschungsinformationssystem des UKE - frei zugänglich